Methods for treating inflammation pain
AssigneeAllergan Sales, Inc.
InventorStephen Donovan
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods for treating neurogenic inflammation pain. The methods include administering an effective amount of a composition which includes a botulinum toxin component and a substance P component to a patient, thereby treating the neurogenic inflammation pain.
Claims29
A method for treating neurogenic inflammation pain, the method comprises administering an effective amount of a composition which comprises a botulinum toxin component and a substance P component to a patient, thereby treating the neurogenic inflammation pain.
A method for inhibiting pain caused by degranulation of mast cells wherein the method comprises administering to a patient an effective amount of a composition which comprises a botulinum toxin component attached to a substance P component, thereby inhibiting degranulation of mast cells.
A method for inhibiting pain caused by degranulation of mast cells and release of inflammation mediating compounds from vascular endothelial cells wherein the method comprises administering to a patient an effective amount of a composition which comprises a botulinum toxin component attached to a substance P component, thereby inhibiting pain caused by degranulation of mast cells and release of inflammation mediating compounds from vascular endothelial cells.
Dependencies are inferred from the claim text.